GlassScriptPhysician profile
Robert Rosen
NPI 1336110832
$1,902.75
in general payments reported to CMS, 2019-2025
24 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $130 · 2021: $183 · 2022: $436 · 2023: $167 · 2024: $298 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $359.70 | 2022-2025 | Nuzyra |
| Amgen INC. | $233.15 | 2024-2025 | Krystexxa |
| Stryker Corporation | $168.01 | 2021-2023 | Ortholoc 2 Lapifuse |
| Boston Scientific Corporation | $146.21 | 2025 | Ranger |
| Organogenesis INC. | $140.23 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $131.48 | 2019-2020 | |
| Horizon Therapeutics Plc | $112.52 | 2022 | |
| Bioventus LLC | $105.44 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $89.89 | 2019 | |
| Next Science LLC | $62.37 | 2023-2024 | Xperience, Blastx, Surgx |
| Zimmer Biomet Holdings, INC. | $49.01 | 2021-2024 | Tapestry |
| Depuy Synthes Sales INC. | $33.56 | 2024 | N/A |
| Anika Therapeutics, INC. | $32.34 | 2024 | Integrity |
| Reel Surgical, INC. | $32.24 | 2019 | |
| Orthofix Medical, INC. | $31.74 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $26.71 | 2021 | |
| Abbott Laboratories | $23.19 | 2021 | |
| Tactile Systems Technology INC | $21.57 | 2025 | |
| Grt US Holding, INC. | $20.21 | 2021 | |
| Convatec INC. | $19.38 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $19.16 | 2020 | |
| Wright Medical Technology, INC. | $16.53 | 2019 | |
| Solventum Corporation | $14.69 | 2024 | 3m Cavilon, Activ.A.C., Promogran Prisma |
| Misonix INC | $13.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rosen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.